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Molecules of the title compound, C19H15BrN4OS, are
essentially planar. Geometric parameters are in the usual
ranges.
Comment
Various 1,2,4-triazoles have been reported to possess anti-
bacterial, antifungal, antitubercular, diuretic, antihypertensive
and anti-inflammatory properties (Burch & Smith, 1966; Mir et
al., 1970; Goswami et al., 1984; Demirayak et al., 2000). On the
basis of such findings, the 1,2,4-triazole nucleus has been
incorporated into a wide variety of therapeutically interesting
compounds to transform them into better drugs (Hendel &
Raid, 1980). In view of the importance of substituted 1,2,4-
triazoles, we attempted to synthesize 3-(2-bromo-5-methoxy-
phenyl)-5-phenyl[1,3]thiazolo[2,3-c][1,2,4]triazole. Instead,
however, the title new triazole, (I), was formed by the reaction
of 2-bromo-5-methoxy-N0-[4-(phenyl)-1,3-thiazol-2yl]benzo-
hydrazide with acetonitrile. The crystal structure of (I) is
reported here.
The molecular structure of compound (I) is shown in Fig. 1.
Bond lengths and angles can be regarded as normal (Allen et
al., 1987). Molecules of (I) are essentially planar (r.m.s.
deviation for all non-H atoms = 0.065 A˚). The S atom of the
thiazole ring is trans to the methyl group attached to the
triazole ring.
Experimental
2-Bromo-5-methoxy-N0-[4-(phenyl)-1,3-thiazol-2yl]benzohydrazide
(4.04 g, 0.01 mol) in POCl3 (5 ml) and acetonitrile (15 ml) was
refluxed for 10 h. The reaction mixture was then cooled, quenched in
ice and the precipitated solid was filtered off. The solid obtained was
recrystallized from a methanol–acetone mixture (1:1 v/v) (yield 58%;
m.p. 435–437 K). Analysis for C19H15BrN4OS: found (calculated): C
53.31 (53.40%), H 3.45 (3.54%), N 13.02 (13.11%).
Crystal data
C19H15BrN4OS
Mr = 427.32
Monoclinic, P21=n
a = 11.9585 (7) A˚
b = 5.0552 (3) A˚
c = 29.0105 (15) A˚
 = 90.863 (5)
V = 1753.56 (17) A˚3
Z = 4
Dx = 1.619 Mg m
3
Mo K radiation
 = 2.48 mm1
T = 173 (2) K
Needle, colourless
0.24  0.09  0.09 mm
Data collection
Stoe IPDS II two-circle
diffractometer
! scans
Absorption correction: multi-scan
[MULABS (Spek, 2003; Blessing,
1995)]
Tmin = 0.588, Tmax = 0.808
18751 measured reflections
3329 independent reflections
2823 reflections with I > 2(I)
Rint = 0.085
max = 25.7

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.034
wR(F 2) = 0.089
S = 1.02
3329 reflections
237 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0561P)2]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.001
max = 0.27 e A˚
3
min = 0.68 e A˚3
H atoms were found in a difference map but they were refined
using a riding model, with C—H = 0.95 A˚ and Uiso(H) = 1.2Ueq(C), or
C—H = 0.98 A˚ and Uiso(H) = 1.5Ueq(C) for methyl H. The methyl
groups were allowed to rotate but not to tip.
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine
structure: SHELXL97 (Sheldrick, 1997); molecular graphics:
PLATON (Spek, 2003); software used to prepare material for
publication: SHELXL97.
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Figure 1
The molecular structure of the title compound, with the atom numbering.
Displacement ellipsoids are drawn at the 50% probability level.
